# DICERNA PHARMACEUTICALS INC (DRNA)

> Institutional ownership reported to the SEC as of Q1 2022, from Form 13F filings. Source: https://holderbook.com/stocks/DRNA/

- Reporting holders: 1
- Reported value: $76.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Close Asset Management Ltd](https://holderbook.com/funds/1718570-close-asset-management-ltd/) | $76.0K | 2,000 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2022 | 1 | $76.0K |
| Q4 2021 | 2 | $169.0K |
| Q3 2021 | 176 | $1.3B |
| Q2 2021 | 205 | $2.3B |
| Q1 2021 | 185 | $1.6B |
| Q4 2020 | 177 | $1.4B |
| Q3 2020 | 173 | $1.1B |
| Q2 2020 | 174 | $1.6B |
| Q1 2020 | 146 | $1.1B |
| Q4 2019 | 170 | $1.3B |
| Q3 2019 | 112 | $840.7M |
| Q2 2019 | 99 | $903.0M |